Autonomix Medical, Inc. (NASDAQ:AMIX) Short Interest Update

Autonomix Medical, Inc. (NASDAQ:AMIX) was the recipient of a large decline in short interest during the month of June. As of June 15th, there was short interest totaling 344,031 shares, a decline of 46.8% from the May 31st total of 646,074 shares. Currently, 5.3% of the company’s stock are short sold. Based on an average daily volume of 146,755 shares, the days-to-cover ratio is presently 2.3 days.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on AMIX shares. Zacks Research upgraded shares of Autonomix Medical to a “hold” rating in a research note on Tuesday, June 2nd. Weiss Ratings upgraded shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research note on Tuesday, June 23rd. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $42.00.

Autonomix Medical Stock Performance

Shares of AMIX stock traded down $0.31 during mid-day trading on Thursday, hitting $6.59. The company’s stock had a trading volume of 652 shares, compared to its average volume of 42,365. Autonomix Medical has a 52-week low of $4.20 and a 52-week high of $55.44. The business has a 50-day moving average price of $7.69 and a 200 day moving average price of $8.88. The stock has a market cap of $3.56 million, a price-to-earnings ratio of -0.09 and a beta of -1.31.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.